Cargando…

Noncoding RNA therapeutics for substance use disorder

Although noncoding RNAs (ncRNAs) have been shown to regulate maladaptive neuroadaptations that drive compulsive drug use, ncRNA-targeting therapeutics for substance use disorder (SUD) have yet to be clinically tested. Recent advances in RNA-based drugs have improved many therapeutic issues related t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seyednejad, Seyed Afshin, Sartor, Gregory C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808746/ https://www.ncbi.nlm.nih.gov/pubmed/36601439 http://dx.doi.org/10.3389/adar.2022.10807

Ejemplares similares

Nanoparticle delivery systems for substance use disorder
por: Kasina, Vishal, et al.
Publicado: (2022)

Noncoding RNA therapeutics — challenges and potential solutions
por: Winkle, Melanie, et al.
Publicado: (2021)

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer
por: Gundara, Justin S, et al.
Publicado: (2015)

Attachment and Therapeutic Alliance in Substance Use Disorders: Initial Findings for Treatment in the Therapeutic Community
por: Rübig, Leonie L., et al.
Publicado: (2021)

Long noncoding RNA: noncoding and not coded
por: Toiber, Debra, et al.
Publicado: (2017)

Long noncoding RNA: noncoding and not coded
por: Toiber, Debra, et al.
Publicado: (2017)

Therapeutic potential of extracellular vesicle‐associated long noncoding RNA
por: Born, Louis J., et al.
Publicado: (2020)

Preclinical and Clinical Development of Noncoding RNA Therapeutics for Cardiovascular Disease
por: Huang, Cheng-Kai, et al.
Publicado: (2020)

Long Noncoding RNA: Regulatory Mechanisms and Therapeutic Potential in Sepsis
por: Wang, Wei, et al.
Publicado: (2021)

Editorial: Noncoding RNA-based spatiotemporal modulation and therapeutics in neuroinflammation
por: Cai, Zhongdi, et al.
Publicado: (2023)

Cerebellar stimulation: A hypothetical therapeutic model for substance use disorders
por: Mangot, Ajish G., et al.
Publicado: (2015)

Addressing substance abuse and violence in substance use disorder treatment and batterer intervention programs
por: Timko, Christine, et al.
Publicado: (2012)

Noncoding-RNA-Based Therapeutics with an Emphasis on Prostatic Carcinoma—Progress and Challenges
por: Nava, Victor E., et al.
Publicado: (2022)

Epigenetic Regulation in Substance Use Disorders
por: McQuown, Susan C., et al.
Publicado: (2010)

Long noncoding RNA (lncRNA) HOTAIR: Pathogenic roles and therapeutic opportunities in gastric cancer
por: Kong, Wencheng, et al.
Publicado: (2021)

Comorbidity and Pattern of Substance Use in Hospitalized Psychiatric Patients
por: Sepehrmanesh, Zahra, et al.
Publicado: (2014)

Women and Substance Use Disorders
por: Hecksher, Dorte, et al.
Publicado: (2009)

Substance P, A Promising Therapeutic Target in Musculoskeletal Disorders
por: Ko, Kyung Rae, et al.
Publicado: (2022)

THERAPEUTIC ALLIANCE AND RELAPSES OF SUBSTANCE USE
por: El Moussaoui, N., et al.
Publicado: (2023)

Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders
por: Dal Farra, Deborah, et al.
Publicado: (2022)

WEB-BASED TREATMENT FOR SUBSTANCE USE DISORDERS: DIFFERENTIAL EFFECTS BY PRIMARY SUBSTANCE
por: Cochran, Gerald, et al.
Publicado: (2015)

Harnessing noncoding RNA‐based macrophage polarization: Emerging therapeutic opportunities for fibrosis
por: Zhou, Dexi, et al.
Publicado: (2020)

A systematic review of substance use and substance use disorder research in Kenya
por: Jaguga, Florence, et al.
Publicado: (2022)

Peptides Used in the Delivery of Small Noncoding RNA
por: Shukla, Ravi S., et al.
Publicado: (2014)

Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis
por: Zhornitsky, Simon, et al.
Publicado: (2015)

Technological Interventions for the Treatment of Substance Use Disorders
por: Schulte, Mieke H.J., et al.
Publicado: (2022)

Brief intervention in substance use disorders
por: Mattoo, Surendra Kumar, et al.
Publicado: (2018)

Noncoding RNA and Cardiomyocyte Proliferation
por: Qu, Shuang, et al.
Publicado: (2017)

Longitudinal Substance Use and Biopsychosocial Outcomes Following Therapeutic Community Treatment for Substance Dependence
por: Staiger, Petra K., et al.
Publicado: (2020)

The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models
por: Aziz, Abdul Maruf Asif, et al.
Publicado: (2016)

Age of onset of substance use and psychosocial problems among individuals with substance use disorders
por: Poudel, Anju, et al.
Publicado: (2017)

Typology of Substance Use Disorder Based on Temperament Dimensions, Addiction Severity, and Negative Emotions
por: Saberi Zafarghandi, Mohammad Bagher, et al.
Publicado: (2018)

Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder
por: Rodrigues, J., et al.
Publicado: (2022)

Coping and Co-Occurrence of Gaming Disorder and Substance Use in Recovering Substance Users
por: Burleigh, Tyrone L., et al.
Publicado: (2022)

Genetics of substance use disorders: a review
por: Deak, Joseph D., et al.
Publicado: (2021)

Decreased FMR1 mRNA levels found in men with substance use disorders
por: Krasteva, Maria, et al.
Publicado: (2020)

Mood Disorders and Substance Use Disorder: A Complex Comorbidity
por: Quello, Susan B., et al.
Publicado: (2005)

Network Analysis of DSM Symptoms of Substance Use Disorders and Frequently Co-Occurring Mental Disorders in Patients with Substance Use Disorder Who Seek Treatment
por: López-Toro, Edith, et al.
Publicado: (2022)

A qualitative assessment of an abstinence-oriented therapeutic community for prisoners with substance use disorders in Kyrgyzstan
por: Azbel, Lyuba, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ijgep1acrs3ra3e1672hcf7f3i